Furthermore, the role of metabolic flexibility and vulnerability in regulating xCT-mediated ferroptosis was summarized, and the current understanding of ferroptosis-induced therapy in ovarian cancer was discussed. Here, SLC7A11 is linked to ovarian carcinoma.